Deep hypothermic circulatory arrest and bivalirudin use in a patient with heparin-induced thrombocytopenia and antiphospholipid syndrome

Journal of Cardiac Surgery

Volumn 22, Issue 1, 2007, Pages 78-82

  Leissner, Kay B ^a,c   Ketchedjian, Ara ^b   Crowley, Richard ^c   Ortega, Rafael ^a   Hesselvik, Jan F ^a   Shemin, Richard J ^c  

^a BOSTON MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN; HEPARIN; HIRULOG; THROMBIN INHIBITOR; WARFARIN;

ADULT; ANTICOAGULATION; ANTIPHOSPHOLIPID SYNDROME; BLOOD CLOTTING TIME; CARDIOPULMONARY BYPASS; CASE REPORT; CLINICAL FEATURE; DEEP HYPOTHERMIC CIRCULATORY ARREST; DISEASE COURSE; FEMALE; HEART TUMOR; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; POSTOPERATIVE PERIOD; POSTOPERATIVE THROMBOSIS; REVIEW; THROMBOEMBOLISM; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT OUTCOME;

ADULT; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; ANTITHROMBINS; BLOOD COAGULATION; CIRCULATORY ARREST, DEEP HYPOTHERMIA INDUCED; FEMALE; HEART ATRIA; HEART NEOPLASMS; HIRUDINS; HUMANS; INFUSIONS, INTRAVENOUS; INTRAOPERATIVE CARE; MYXOMA; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS; THROMBOCYTOPENIA;

EID: 33846288560     PISSN: 08860440     EISSN: 15408191     Source Type: Journal    
DOI: 10.1111/j.1540-8191.2007.00351.x     Document Type: Review

References (30)

1. Natelson EA, Lynch EC, Alfrey CP Jr et al: Heparin-induced thrombocytopenia. An unexpected response to treatment of consumption coagulopathy. Ann Intern Med 1969;7:1121-1125.
2. Weismann RE, Tobin RW: Arterial embolism occurring during systemic heparin therapy. AMA Arch Surg 1958;76:219-225.
3. Jang IK, Hursting MJ: When heparins promote thrombosis: Review of heparin-induced thrombocytopenia. Circulation 2005;111:2671-2683.
4. Warkentin TE, Greinacher A: Heparin-induced thrombocytopenia and cardiac surgery. Ann Thorac Surg 2003;76:2121-2131.
5. Franchini M: Heparin-induced thrombocytopenia: an update. Thromb J 2005;Oct 4; 3:14-19.
6. Warkentin TE, Aird WC, Rand JH: Platelet-Endothelial Interactions: Sepsis, HIT, and Antiphospholipid Syndrome. Hematology 2003;1:497-519.
7. Berkun Y, Elami A, Meir K, et al: Increased morbidity and mortality in patients with antiphospholipid syndrome undergoing valve replacement surgery. J Thorac Cardiovasc Surg 2004;127:414-420.
8. Dornan RI: Acute postoperative biventricular failure associated with antiphospholipid antibody syndrome. Br J Anaesth 2004;92:748-754.
9. Nakayama M, Kumon K, Yahagi N, et al: Antiphospholipid antibody syndrome in a case with redo coronary artery bypass grafting under cardiopulmonary bypass. Surg Today 1998;28:423-426.
10. Ciocca RG, Choi J, Graham AM: Antiphospholipid antibodies lead to increased risk in cardiovascular surgery. Am J Surg 1995;170:198-200.
11. Green JA, Spiess BD: Current status of antifibrinolytics in cardiopulmonary bypass and elective deep hypothermic circulatory arrest. Anesthesiol Clin North America 2003;21:527-551.
12. Merry AF: Bivalirudin, blood loss, and graft patency in coronary artery bypass surgery. Semin Thromb Hemost 2004;30:337-346.
13. Koster A, Yeter R, Buz S, et al: Assessment of hemostatic activation during cardiopulmonary bypass for coronary artery bypass grafting with bivalirudin: Results of a pilot study. J Thorac Cardiovasc Surg 2005;129:1391-1394.
14. Clayton SB, Acsell JR, Crumbley AJ 3rd, et al: Cardiopulmonary bypass with bivalirudin in type II heparin-induced thrombocytopenia. Ann Thorac Surg 2004;78:2167-2169.
15. Gordon G, Rastegar H, Schumann R, et al: Successful use of bivalirudin for cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia. J Cardiothorac Vasc Anesth 2003;17:632-635.
16. Weitz JI, Bates SM: New anticoagulants. J Thromb Haemost 2005;3:1843-1853.
17. Koster A, Spiess B, Chew DP, et al: Effectiveness of bivalirudin as a replacement for heparin during cardiopulmonary bypass in patients undergoing coronary artery bypass grafting. Am J Cardiol 2004;93:356-359.
18. Warkentin TE, Barkin RL: Newer strategies for the treatment of heparin-induced thrombocytopenia. Pharmacotherapy 1999;19:181-195.
19. Walls JT, Curtis JJ, Silver D, et al: Heparin-induced thrombocytopenia in open heart surgical patients: Sequelae of late recognition. Ann Thorac Surg 1992;53:787-791.
20. Jorgensen P, Hansen PR: Antiphospholipid antibodies and ischaemic heart disease. J Intern Med 1993;233:291-293.
21. Basso C, Bottio T, Rubino M, et al: Antiphospholipid syndrome and right atrial mass. J Thorac Cardiovasc Surg 2005;130:1462-1463.
22. Plein D, Van Camp G, Efira A, et al: Intracardiac thrombi associated with antiphospholipid antibodies. J Am Soc Echocardiogr 1996;9:891-893.
23. Wilson WA, Gharavi AE, Koike T, et al: International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an international workshop. Arthritis Rheum 1999;42:1309-1311.
24. Roubey RA: New approaches to prevention of thrombosis in the antiphospholipid syndrome: Hopes, trials, and tribulations. Arthritis Rheum 2003;48:3004-3008.
25. Dyke CM, Koster A, Veale JJ, et al: Preemptive use of bivalirudin for urgent on-pump coronary artery bypass grafting in patients with potential heparin-induced thrombocytopenia. Ann Thorac Surg 2005;80:299-303.
26. Lincoff AM, Bittl JA, Harrington RA, et al: Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. JAMA 2003;289:853-863.
27. Merry AF, Raudkivi PJ, Middleton NG, et al: Bivalirudin versus heparin and protamine in off-pump coronary artery bypass surgery. Ann Thorac Surg 2004;77:925-931.
28. Koster A, Yeter R, Buz S, et al: Assessment of hemostatic activation during cardiopulmonary bypass for coronary artery bypass grafting with bivalirudin: Results of a pilot study. J Thorac Cardiovasc Surg 2000;129:1391-1394.
29. Mann MJ, Tseng E, Ratcliffe M, et al: Use of bivalirudin, a direct thrombin inhibitor, and its reversal with modified ultrafiltration during heart transplantation in a patient with heparin-induced thrombocytopenia. J Heart Lung Transplant 2005;24:222-225.
30. Greinacher A: The use of direct thrombin inhibitors in cardiovascular surgery in patients with heparin-induced thrombocytopenia. Semin Thromb Hemost 2004;30:315-327.